Coronary artery disease in giant cell arteritis: a systematic review and meta-analysis

Patompong Ungprasert1, Matthew J Koster1, Kenneth J Warrington1

  • 1Division of Rheumatology, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

Insights

Giant cell arteritis (GCA) is a chronic inflammatory condition. This meta-analysis found no statistically significant increased risk of coronary artery disease (CAD) in patients with GCA compared to controls.

Area of Science:

  • Rheumatology
  • Cardiology
  • Epidemiology

Background:

  • Giant cell arteritis (GCA) is a systemic vasculitis affecting large arteries.
  • Chronic systemic inflammation is a known risk factor for cardiovascular diseases.
  • The relationship between GCA and coronary artery disease (CAD) risk requires clarification.

Purpose of the Study:

  • To systematically review and meta-analyze observational studies evaluating the association between GCA and the risk of developing CAD.
  • To quantify the pooled risk of CAD in individuals diagnosed with GCA.

Main Methods:

  • Systematic review and meta-analysis of observational studies.
  • Inclusion of studies reporting relative risks, hazard ratios, or standardized incidence ratios for CAD in GCA patients versus controls.
  • Calculation of pooled risk ratios and 95% confidence intervals using a random-effect model.

Main Results:

  • Six studies comprising 10,868 GCA patients and 245,323 controls were analyzed.
  • The pooled risk ratio for CAD in GCA patients was 1.51 (95% CI: 0.88-2.61), which was not statistically significant.
  • High statistical heterogeneity (I² = 97%) was observed across the included studies.

Conclusions:

  • This meta-analysis did not demonstrate a statistically significant increased risk of CAD in patients with GCA.
  • Unlike other chronic inflammatory conditions, GCA may not confer a heightened risk for CAD.
  • Further research may be warranted to explore potential confounding factors or specific subgroups.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...